American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

ACC backs AMA resolution to boost lung cancer and heart disease screenings in smokers with low-dose CT scans
Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time.
A closer look at GE HealthCare's new affordable cardiac CT scanner
As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals.
Cardiologists using less contrast in the cath lab—but there is room to improve
Researchers emphasized that minimizing procedural contrast use is an effective way to reduce the risk of post-PCI acute kidney injury.
Cardiologists make history, use new robotic imaging system for first time
Researchers believe a new robotic TEE system could improve the long-term health of interventional echocardiographers in addition to several other key benefits.
Cardiology employment models undergoing a dramatic shift
Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.

Paul M. Ridker, MD, MPH, director of the Center for Cardiovascular Disease Prevention, and the Eugene Braunwald Professor of Medicine, cardiovascular medicine, Brigham and Women's Hospital, who presented the results of late-breaking study on residual inflammatory risk in contemporary statin treated patients. The study used an analyses of 31,197 patients in the PROMINENT, REDUCE-IT and STRENGTH trials.

What new data can teach cardiologists about statin use and treating inflammation

"If we do not attack the inflammation, we just are not going to get the best outcomes for our patients," one researcher told Cardiovascular Business.

Janet Wei at Cedars-Sinai Hospital explains INOCA and MINOCA at ACC 2023.

Understanding INOCA and MINOCA epidemiology

Janet Wei, MD, associate medical director of the Biomedical Imaging Research Institute, and co-director of the stress echocardiography lab at Cedars-Sinai Hospital, explains the current information on the INOCA and MINOCA.

Raj Makkar, MD, Cedars-Sinai’s vice president of Cardiovascular Innovation and Intervention and the Stephen R. Corday, MD, Chair in Interventional Cardiology, explains the ACC 2023 results on the safety and efficacy of transcatheter edge-to-edge mitral valve repair in degenerative mitral regurgitation (MR) study. It was a review of data is from the STS/ACC TVT Registry that was presented at the American College of Cardiology (ACC) 2023 meeting.

New data on real-world TEER outcomes in patients with degenerative MR

TEER can significantly improve a patient's chances of survival, new findings confirm.

Cardiologists, cardiac surgeons support new bill that could limit Medicare cuts

More than 100 U.S. medical societies—including the ACC, ASNC and others—have united in support of a new bill that would make a long-term impact on Medicare payments.

American College of Cardiology shares new HFpEF recommendations as cases continue to rise

HFpEF now accounts for a majority of heart failure cases, highlighting the importance of ensuring both primary care providers and dedicated heart teams know as much about this topic as possible.

New details on the link between CVD and cancer, from a study of 27M patients

According to the large new study, published in JACC: CardioOncology, atherosclerotic CVD is associated with an especially high risk of cancer.

Marielle Scherrer Crosbie and Tomas Neilan explain the STOP-CA trial and how statins can help prevent cardiotoxicity from anthracycline chemo agents.

Statins may help prevent anthracycline cardiotoxicity in chemotherapy

The STOP-CA trial showed that statins can help chemotherapy patients avoid potential side effects related to anthracycline agents. Co-principal investigators Marielle Scherrer-Crosbie, MD, and Tomas Neilan, MD, discussed the details of that trial at ACC.23.

VIDEO: American Society of Nuclear Cardiology (ASNC) President Mouaz Al-Mallah, MD, chair of cardiovascular PET and associate director of nuclear cardiology, Houston Methodist DeBakey Heart and Vascular Center, and ASNC President-elect Larry Phillips, MD, director of nuclear cardiology, NYU Langone, outline the new technologies available and why upgrading cardiac nuclear labs matters and what is the ROI. #ASNC

What is the ROI for upgrading nuclear cardiology labs?

Some nuclear cardiology labs are still using SPECT systems that are 20-25 years old. Is it time to make an upgrade?

American College of Cardiology (ACC)

ACC backs AMA resolution to boost lung cancer and heart disease screenings in smokers with low-dose CT scans

A closer look at GE HealthCare's new affordable cardiac CT scanner

Cardiologists using less contrast in the cath lab—but there is room to improve

Cardiologists make history, use new robotic imaging system for first time

Cardiology employment models undergoing a dramatic shift